Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | PAM | P19021 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.39 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.39 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 3/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CHAT | P28329 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5542626 | 1.00 | IDO1 (0.41) | IDO1PAMPTGER4PTGER3PTGER2 | |
| SCHEMBL482877 | 0.76 | MAOB (0.30) | MAOB | |
| SCHEMBL9199675 | 0.76 | MAOB (0.30) | MAOB | |
| SCHEMBL482794 | 0.76 | MAOB (0.30) | MAOB | |
| SCHEMBL3515158 | 0.76 | MAOB (0.30) | MAOB | |
| SCHEMBL1069078 | 0.74 | MAOB (0.33) | MAOB | |
| SCHEMBL294593 | 0.74 | MAOB (0.33) | MAOB | |
| SCHEMBL6067510 | 0.73 | — | — | |
| SCHEMBL2701351 | 0.73 | — | — | |
| SCHEMBL2701350 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420141-B2 | Food coloring | PEPSICO, INC. (US) | 2013-04-16 | — | — | US | claimed |
| US-20070110851-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PEPSICO, INC. | 2007-05-17 | — | — | US | claimed |
| EP-1782701-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PepsiCo, Inc. (US) | 2007-05-09 | — | — | EP | claimed |
| US-20040198741-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | WYETH | 2004-10-07 | — | — | US | claimed |
| US-20040091589-A1 | Prevention of synthetic color fading in beverages using botanically derived color stabilizers | PEPSICO, INC. | 2004-05-13 | — | — | US | claimed |
| US-20030195213-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | BAILEY THOMAS R (US) | 2003-10-16 | — | — | US | claimed |
| EP-1128832-A4 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRAL INFECTIONS AND ASSOCIATED DISEASES | VIROPHARMA INC (US) | 2003-03-05 | — | — | EP | claimed |
| EP-1128832-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRAL INFECTIONS AND ASSOCIATED DISEASES | Viropharma Incorporated (US) | 2001-09-05 | — | — | EP | claimed |
| WO-2000010573-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING VIRAL INFECTIONS AND ASSOCIATED DISEASES | VIROPHARMA INCORPORATED (US) | 2000-03-02 | — | — | WO | claimed |
| US-11781037-B2 | High-durability antifogging coating film and coating composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-10-10 | — | — | US | disclosed |
| CN-116143660-A | Compound, curing agent composition, resin composition, coating composition, and resin cured product | 旭化成株式会社 | 2023-05-23 | — | — | CN | disclosed |
| US-20230086403-A1 | LAMINATE, HARD COATING FILM, AND COATING MATERIAL COMPOSITION | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-03-23 | — | — | US | disclosed |
| EP-4116085-A1 | LAMINATE, HARD-COAT COATING FILM, AND COATING MATERIAL COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2023-01-11 | — | — | EP | disclosed |
| CN-111684030-B | High-durability antifogging coating film and coating composition | 旭化成株式会社 | 2022-11-01 | — | — | CN | disclosed |
| US-20060287527-A1 | Process for producing acrylic acid derivative | NIPPON SODA CO., LTD. (JP) | 2006-12-21 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| US-20040152894-A1 | Process for producing acrylic acid derivative | NIPPON SODA CO. LTD (JP) | 2004-08-05 | — | — | US | disclosed |
| US-20040091589-A1 | Prevention of synthetic color fading in beverages using botanically derived color stabilizers | PEPSICO, INC. | 2004-05-13 | — | — | US | disclosed |
| EP-1142857-A1 | PROCESSES FOR PRODUCING ACRYLIC ACID DERIVATIVE | NIPPON SODA CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152894-A1 | Process for producing acrylic acid derivative | OXGR1, GART, HAO2 | IDO1 3478/4885PAM 300/4885PTGER4 2516/4885 |
| US-20030195213-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | RXRG, TREH, RARG | IDO1 1838/4885PAM 1686/4885PTGER4 2569/4885 |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | IDO1 3181/4885PAM 1855/4885PTGER4 3830/4885 |
| US-20040198741-A1 | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | RXRG, TREH, RARG | IDO1 1838/4885PAM 1686/4885PTGER4 2569/4885 |
| US-20060287527-A1 | Process for producing acrylic acid derivative | APEH, HAAO, ASNS | IDO1 3753/4885PAM 417/4885PTGER4 2858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.